Consumer

Lane-level opportunity view across countries and weekly pulses, backed by published signals and evidence lockers.

Published Opportunities
4
Visible Results
2
Countries
1
Weeks
1

The 'RFK 12' Peptide Directory

The FDA is reclassifying 12 unapproved peptides, potentially moving them into the legal compounding pharmacy lane. This signals a regulatory truce that could 10x the legal biohacking market.

gatekeeperndgregcliff
Opportunity
81
Confidence
92
Country
Brazil
Top Countries in this Lane